Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
14.57
-0.23 (-1.54%)
Nov 5, 2024, 11:13 AM EST - Market open
RDY's stock price has decreased by -77.33% in the past year and price targets may not have had time to catch up.
Dr. Reddy's Laboratories Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$87.00
Upside
+497.12%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Buy Maintains $81 → $87 | Buy | Maintains | $81 → $87 | +497.12% | Jul 30, 2024 |
Barclays | Barclays | Buy Maintains $80 → $81 | Buy | Maintains | $80 → $81 | +455.94% | May 8, 2024 |
Barclays | Barclays | Buy Maintains $75 → $80 | Buy | Maintains | $75 → $80 | +449.07% | Jan 29, 2024 |
Barclays | Barclays | Buy Maintains $67 → $70 | Buy | Maintains | $67 → $70 | +380.44% | Jun 1, 2023 |
Barclays | Barclays | Buy Maintains $66 → $67 | Buy | Maintains | $66 → $67 | +359.85% | Oct 31, 2022 |
Barclays | Barclays | Buy Maintains $69 → $66 | Buy | Maintains | $69 → $66 | +352.99% | Oct 25, 2022 |
Barclays | Barclays | Buy Maintains $68 → $69 | Buy | Maintains | $68 → $69 | +373.58% | Sep 12, 2022 |
Barclays | Barclays | Buy Maintains $70 → $68 | Buy | Maintains | $70 → $68 | +366.71% | Jul 25, 2022 |
Barclays | Barclays | Buy Maintains $69 → $70 | Buy | Maintains | $69 → $70 | +380.44% | May 24, 2022 |
Barclays | Barclays | Buy Maintains $78 → $80 | Buy | Maintains | $78 → $80 | +449.07% | Nov 1, 2021 |
Barclays | Barclays | Hold → Buy Upgrades $56 → $70 | Hold → Buy | Upgrades | $56 → $70 | +380.44% | Feb 2, 2021 |
CLSA | CLSA | Strong Buy → Buy Downgrades n/a | Strong Buy → Buy | Downgrades | n/a | n/a | Jan 28, 2020 |
Citigroup | Citigroup | Strong Sell → Strong Buy Upgrades n/a | Strong Sell → Strong Buy | Upgrades | n/a | n/a | Jan 9, 2020 |
Barclays | Barclays | Hold Initiates $39 | Hold | Initiates | $39 | +167.67% | Jun 11, 2019 |
Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 20, 2019 |
Jefferies | Jefferies | Sell Maintains $32 → $31 | Sell | Maintains | $32 → $31 | +109.40% | Nov 1, 2017 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.